151 related articles for article (PubMed ID: 31414076)
1. The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction.
Shino MY; DerHovanessian A; Sayah DM; Saggar R; Ying Xue Y; Ardehali A; Stripp BR; Ross DJ; Lynch JP; Elashoff RM; Weigt SS; Belperio JA
OBM Transplant; 2018; 2(4):. PubMed ID: 31414076
[TBL] [Abstract][Full Text] [Related]
2. The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Huynh RH; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
PLoS One; 2017; 12(7):e0180281. PubMed ID: 28686641
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
[TBL] [Abstract][Full Text] [Related]
4. Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.
Shino MY; Todd JL; Neely ML; Kirchner J; Frankel CW; Snyder LD; Pavlisko EN; Fishbein GA; Schaenman JM; Mason K; Kesler K; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Weigt SS; Belperio JA
Am J Transplant; 2022 Sep; 22(9):2169-2179. PubMed ID: 35634722
[TBL] [Abstract][Full Text] [Related]
5. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455
[TBL] [Abstract][Full Text] [Related]
6. CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Respir Crit Care Med; 2013 Nov; 188(9):1117-25. PubMed ID: 24063316
[TBL] [Abstract][Full Text] [Related]
7. Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study.
Todd JL; Weber JM; Kelly FL; Neely ML; Nagler A; Carmack D; Frankel CW; Brass DM; Belperio JA; Budev MM; Hartwig MG; Martinu T; Reynolds JM; Shah PD; Singer LG; Snyder LD; Weigt SS; Palmer SM
J Heart Lung Transplant; 2023 Jun; 42(6):741-749. PubMed ID: 36941179
[TBL] [Abstract][Full Text] [Related]
8. BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.
Todd JL; Weber JM; Kelly FL; Neely ML; Mulder H; Frankel CW; Nagler A; McCrae C; Newbold P; Kreindler J; Palmer SM
Chest; 2023 Sep; 164(3):670-681. PubMed ID: 37003354
[TBL] [Abstract][Full Text] [Related]
9. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
[TBL] [Abstract][Full Text] [Related]
12. Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.
Shino MY; Li N; Todd JL; Neely ML; Kirchner J; Kopetskie H; Sever ML; Frankel CW; Snyder LD; Pavlisko EN; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Sam Weigt S; Belperio JA
Am J Transplant; 2021 Oct; 21(10):3401-3410. PubMed ID: 33840162
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
14. CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.
Weigt SS; Derhovanessian A; Liao E; Hu S; Gregson AL; Kubak BM; Saggar R; Saggar R; Plachevskiy V; Fishbein MC; Lynch JP; Ardehali A; Ross DJ; Wang HJ; Elashoff RM; Belperio JA
Am J Transplant; 2012 Feb; 12(2):477-84. PubMed ID: 22152000
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
17. Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection.
Hostetler HP; Neely ML; Kelly FL; Belperio JA; Budev M; Reynolds JM; Shah PD; Singer LG; Snyder LD; Palmer SM; Todd JL
Transplant Direct; 2021 Apr; 7(4):e685. PubMed ID: 34549083
[TBL] [Abstract][Full Text] [Related]
18. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
[TBL] [Abstract][Full Text] [Related]
19. Infectious Triggers of Chronic Lung Allograft Dysfunction.
Gregson AL
Curr Infect Dis Rep; 2016 Jul; 18(7):21. PubMed ID: 27221821
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction.
Peghin M; Los-Arcos I; Hirsch HH; Codina G; Monforte V; Bravo C; Berastegui C; Jauregui A; Romero L; Cabral E; Ferrer R; Sacanell J; Román A; Len O; Gavaldà J
Clin Infect Dis; 2019 Sep; 69(7):1192-1197. PubMed ID: 30561555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
